Lap-Band Gains Panel Support For Use In Less Obese, Less Sick Patients
This article was originally published in The Gray Sheet
Executive Summary
An FDA panel has cleared the path for the agency to approve an expanded indication for Allergan's Lap-Band surgical obesity treatment to include at least 27 million additional people.